235 related articles for article (PubMed ID: 31585141)
1. Invasive pulmonary aspergillosis: comparative analysis in cancer patients with underlying haematologic malignancies versus solid tumours.
Dib RW; Khalil M; Fares J; Hachem RY; Jiang Y; Dandachi D; Chaftari AM; Raad II
J Hosp Infect; 2020 Mar; 104(3):358-364. PubMed ID: 31585141
[TBL] [Abstract][Full Text] [Related]
2. Invasive pulmonary aspergillosis in patients with solid tumours: risk factors and predictors of clinical outcomes.
Dandachi D; Wilson Dib R; Fernández-Cruz A; Jiang Y; Chaftari AM; Hachem R; Raad I
Ann Med; 2018 Dec; 50(8):713-720. PubMed ID: 30230385
[TBL] [Abstract][Full Text] [Related]
3. COVID-19-associated pulmonary aspergillosis (CAPA) in hematological patients: Could antifungal prophylaxis be necessary? A nationwide study.
Tamayo-Velasco Á; López-Herrero R; Gómez-García LM; Sánchez-de Prada L; Aguilar-Monserrate G; Martín-Fernández M; Bardají-Carrillo M; Álvaro-Meca A; Tamayo E; Resino S; Miramontes-González JP; Peñarrubia-Ponce MJ
J Infect Public Health; 2024 Jun; 17(6):939-946. PubMed ID: 38613930
[TBL] [Abstract][Full Text] [Related]
4. Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients.
Nguyen MH; Leather H; Clancy CJ; Cline C; Jantz MA; Kulkarni V; Wheat LJ; Wingard JR
Biol Blood Marrow Transplant; 2011 Jul; 17(7):1043-50. PubMed ID: 21087680
[TBL] [Abstract][Full Text] [Related]
5. Treating invasive aspergillosis in patients with hematologic malignancy: diagnostic-driven approach versus empiric therapies.
Dib RW; Hachem RY; Chaftari AM; Ghaly F; Jiang Y; Raad I
BMC Infect Dis; 2018 Dec; 18(1):656. PubMed ID: 30545320
[TBL] [Abstract][Full Text] [Related]
6. Voriconazole Resistance and Mortality in Invasive Aspergillosis: A Multicenter Retrospective Cohort Study.
Lestrade PP; Bentvelsen RG; Schauwvlieghe AFAD; Schalekamp S; van der Velden WJFM; Kuiper EJ; van Paassen J; van der Hoven B; van der Lee HA; Melchers WJG; de Haan AF; van der Hoeven HL; Rijnders BJA; van der Beek MT; Verweij PE
Clin Infect Dis; 2019 Apr; 68(9):1463-1471. PubMed ID: 30307492
[TBL] [Abstract][Full Text] [Related]
7. Invasive pulmonary aspergillosis in non-neutropenic patients: analysis of a 14-month prospective clinical experience.
Russo A; Falcone M; Vena A; Venditti C; Mancini C; Morelli A; Venditti M
J Chemother; 2011 Oct; 23(5):290-4. PubMed ID: 22005062
[TBL] [Abstract][Full Text] [Related]
8. Invasive pulmonary aspergillosis in critically ill patients with hematological malignancies.
Pardo E; Lemiale V; Mokart D; Stoclin A; Moreau AS; Kerhuel L; Calvet L; Valade S; De Jong A; Darmon M; Azoulay E
Intensive Care Med; 2019 Dec; 45(12):1732-1741. PubMed ID: 31599334
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics, radiologic findings, risk factors and outcomes of serum galactomannan-negative invasive pulmonary aspergillosis.
Jung J; Kim MY; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
J Microbiol Immunol Infect; 2018 Dec; 51(6):802-809. PubMed ID: 28712819
[TBL] [Abstract][Full Text] [Related]
10. Combining standard clinical methods with PCR showed improved diagnosis of invasive pulmonary aspergillosis in patients with hematological malignancies and prolonged neutropenia.
Paholcsek M; Fidler G; Konya J; Rejto L; Mehes G; Bukta E; Loeffler J; Biro S
BMC Infect Dis; 2015 Jul; 15():251. PubMed ID: 26126706
[TBL] [Abstract][Full Text] [Related]
11. Clinical experience of the use of voriconazole, caspofungin or the combination in primary and salvage therapy of invasive aspergillosis in haematological malignancies.
Raad II; Zakhem AE; Helou GE; Jiang Y; Kontoyiannis DP; Hachem R
Int J Antimicrob Agents; 2015 Mar; 45(3):283-8. PubMed ID: 25455847
[TBL] [Abstract][Full Text] [Related]
12. Management of invasive aspergillosis in patients with COPD: rational use of voriconazole.
Ader F; Bienvenu AL; Rammaert B; Nseir S
Int J Chron Obstruct Pulmon Dis; 2009; 4():279-87. PubMed ID: 19684861
[TBL] [Abstract][Full Text] [Related]
13. Concurrent lung infections in patients with hematological malignancies and invasive pulmonary aspergillosis: how firm is the Aspergillus diagnosis?
Georgiadou SP; Kontoyiannis DP
J Infect; 2012 Sep; 65(3):262-8. PubMed ID: 22580034
[TBL] [Abstract][Full Text] [Related]
14. Clinical features of invasive pulmonary aspergillosis vs. colonization in COPD patients distributed by gold stage.
Barberan J; Sanz F; Hernandez JL; Merlos S; Malmierca E; Garcia-Perez FJ; Sanchez-Haya E; Segarra M; Garcia de la Llana F; Granizo JJ; Gimenez MJ; Aguilar L
J Infect; 2012 Nov; 65(5):447-52. PubMed ID: 22863904
[TBL] [Abstract][Full Text] [Related]
15. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: a case control study from China.
Xu H; Li L; Huang WJ; Wang LX; Li WF; Yuan WF
Clin Microbiol Infect; 2012 Apr; 18(4):403-8. PubMed ID: 22023558
[TBL] [Abstract][Full Text] [Related]
16. Invasive pulmonary aspergillosis in non-neutropenic patients with and without underlying disease: a single-centre retrospective analysis of 52 subjects.
Dai Z; Zhao H; Cai S; Lv Y; Tong W
Respirology; 2013 Feb; 18(2):323-31. PubMed ID: 23051143
[TBL] [Abstract][Full Text] [Related]
17. Fungal infections of the central nervous system and paranasal sinuses in onco-haematologic patients. Epidemiological study reporting the diagnostic-therapeutic approach and outcome in 89 cases.
Candoni A; Klimko N; Busca A; Di Blasi R; Shadrivova O; Cesaro S; Zannier ME; Verga L; Forghieri F; Calore E; Nadali G; Simonetti E; Muggeo P; Quinto AM; Castagnola C; Cellini M; Del Principe MI; Fracchiolla N; Melillo L; Piedimonte M; Zama D; Farina F; Giusti D; Mosna F; Capelli D; Delia M; Picardi M; Decembrino N; Perruccio K; Vallero S; Aversa F; Fanin R; Pagano L;
Mycoses; 2019 Mar; 62(3):252-260. PubMed ID: 30565742
[TBL] [Abstract][Full Text] [Related]
18. Invasive pulmonary aspergillosis is associated with adverse clinical outcomes in critically ill patients receiving veno-venous extracorporeal membrane oxygenation.
Rodriguez-Goncer I; Thomas S; Foden P; Richardson MD; Ashworth A; Barker J; Geraghty CG; Muldoon EG; Felton TW
Eur J Clin Microbiol Infect Dis; 2018 Jul; 37(7):1251-1257. PubMed ID: 29623451
[TBL] [Abstract][Full Text] [Related]
19. Invasive pulmonary aspergillosis in patients with hematologic malignancies: survival and prognostic factors.
Subirà M; Martino R; Franquet T; Puzo C; Altés A; Sureda A; Brunet S; Sierra J
Haematologica; 2002 May; 87(5):528-34. PubMed ID: 12010668
[TBL] [Abstract][Full Text] [Related]
20. Initial use of combination treatment does not impact survival of 106 patients with haematologic malignancies and mucormycosis: a propensity score analysis.
Kyvernitakis A; Torres HA; Jiang Y; Chamilos G; Lewis RE; Kontoyiannis DP
Clin Microbiol Infect; 2016 Sep; 22(9):811.e1-811.e8. PubMed ID: 27085727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
